f11photo/iStock via Getty Images Hudson Pacific Properties ( HPP ) has reverted to its cheapest ever multiple on the aggregation of a perfect storm of headwinds, including a suspended dividend, unfavorable debt maturities, and a San Francisco office vacancy rate that continues to hover far above the national U.S. average. The office REIT engineered a 1-for-7 reverse stock split in November and has...
f11photo/iStock via Getty Images Hudson Pacific Properties ( HPP ) has reverted to its cheapest ever multiple on the aggregation of a perfect storm of headwinds, including a suspended dividend, unfavorable debt maturities, and a San Francisco office vacancy rate that continues to hover far above the national U.S. average. The office REIT engineered a 1-for-7 reverse stock split in November and has since seen the value of its stock dip by over 50% since then. The intense selloff, with HPP also down 97% more broadly over the last 5 years, reflects front-loaded debt maturities and a San Francisco office vacancy rate that stood at 24.7% as of the end of January. This was a 650 basis points difference from the national U.S. vacancy rate of 18.2%, with HPP's in-service office portfolio ending its fiscal 2025 fourth quarter with a 76.3% occupancy rate. The bullish play here is that not only is this occupancy rate on the up, boosted by demand from AI companies for office space in San Francisco. The city actually saw its vacancy rate dip by 460 basis points year-over-year, but it remains one of the highest in the U.S. The REIT's in-service studio portfolio continued to show weakness, with the total 67.1% leased, a significant drop from 73.8% a year ago. Hudson Pacific Properties Fiscal 2025 Fourth Quarter Supplemental Hudson Pacific Properties Fiscal 2025 Fourth Quarter Supplemental HPP's upcoming debt maturities represent its most poignant risk, with the REIT facing $540.77 million in debt repayments this year, dropping only slightly to $506.52 million in 2027. For context, HPP held cash and cash equivalents of $138.4 million at the end of the fourth quarter. This divergence means the REIT needs to sell off its assets to meet repayments this year and next, with HPP holding total debt of $2.83 billion at an effective interest rate of 5.0%. The blended years to maturity of this is 2.6 years, representing a material wall of debt that the REIT needs to refinance and address thr...
Key PointsDriehaus Capital Management added 7,704,785 Eos Energy Enterprises shares in the fourth quarter; the estimated transaction value was $110.72 million.
Key PointsDriehaus Capital Management added 7,704,785 Eos Energy Enterprises shares in the fourth quarter; the estimated transaction value was $110.72 million.
RHJ/iStock via Getty Images Wheaton Precious Metals ( WPM ) +1.4% in early trading Friday after reporting better than expected Q4 adjusted earnings , raising its dividend payout, and forecasting significantly higher production in 2026. Q4 net earnings soared to US$558.3M from US$88.1M in the year-earlier quarter, as revenues more than doubled to US$864.7M, sparked by higher gold and silver prices ...
RHJ/iStock via Getty Images Wheaton Precious Metals ( WPM ) +1.4% in early trading Friday after reporting better than expected Q4 adjusted earnings , raising its dividend payout, and forecasting significantly higher production in 2026. Q4 net earnings soared to US$558.3M from US$88.1M in the year-earlier quarter, as revenues more than doubled to US$864.7M, sparked by higher gold and silver prices and more metals production. Q4 a ttributable gold equivalent production rose 8% Y/Y to 205K oz, with gold output up 10% to 130K oz, primarily due to stronger production at Salobo, which achieved a new quarterly record, and Antamina, coupled with the commencement of production at Blackwater. For the full year, Wheaton ( WPM ) produced 689,864 gold equivalent oz, up from 635,488 oz in 2024 and exceeding company guidance of 600K-670K oz. FY 2025 gold production gained 9.2% to 416,171 f rom 381,248 oz in 2024, silver output rose 6.3% to 22,289 oz from 20,959 oz in 2024, cobalt production nearly doubled to 2,460 oz, while palladium output fell 34% to 10,265 oz from 15,632 in the previous year. Wheaton ( WPM ) confirmed the prior guidance for FY 2026 output of 860K-940K gold equivalent oz, to be driven mainly by an additional 70K gold equivalent oz stream from the Antamina site, which will start generating production in April. More on Wheaton Precious Metals Wheaton Precious Metals: Wait For Risk Clarification BHP Signs Wheaton Precious Metals Up For Worst Silver FOMO Deal Of The Century Wheaton Precious Metals: Streaming High-Margin Silver And Gold Profits
If the long-mooted third instalment of the 80s sword and sorcery series finally gets off the ground, it could be Arnie’s chance to go from ageing action hero to cinematic totem If you’re a fan of 1980s and 1990s Arnold Schwarzenegger , his late-era career has probably come as a bit of a disappointment. The Austrian oak was once Hollywood’s most reliable tool for punching killer robots, but he’s ne...
If the long-mooted third instalment of the 80s sword and sorcery series finally gets off the ground, it could be Arnie’s chance to go from ageing action hero to cinematic totem If you’re a fan of 1980s and 1990s Arnold Schwarzenegger , his late-era career has probably come as a bit of a disappointment. The Austrian oak was once Hollywood’s most reliable tool for punching killer robots, but he’s never really had his Unforgiven moment. Despite an absurdly influential run of science fiction and fantasy movies, Schwarzenegger has missed out on the sort of grizzled, late-career reckoning that might have deconstructed his own youthful myth, just as Clint Eastwood’s epic 1992 western confronted the very legend the actor-director spent decades building. It’s not as if Hollywood hasn’t tried. In fact, studios have spent the last decade or so trying to produce Schwarzenegger ’s “old warrior” phase, as if prodding the action hero myth with a stick to see if it still roars. The problem is, nothing has quite landed. Terminator: Dark Fate turned the T-800 into a retired drapery salesman reflecting on his own violent past. Maggie had him as a grieving father in a quiet zombie family drama. Aftermath is essentially a sombre meditation on grief that briefly veers into revenge thriller territory. None quite managed to become the monument to the Schwarzenegger enigma that the actor’s era-defining body of work seemed to demand. If Arnold fans wanted the sort of late-career statement that turns an ageing action star into a cinematic totem, they instead got an increasingly mortal-looking man who turns up in mid-budget streaming thrillers looking faintly concerned. Continue reading...
Douglas Rissing/iStock via Getty Images In the recent past, U.S. economic policy has been centered on the monetary policy of the Federal Reserve. Going back to 2008 or so, the dominating policy of the government has been the "quantitative" stance of the Federal Reserve System. The system was constructed and implemented while Ben Bernanke was the Chairman of the Fed's Board of Governors and then fo...
Douglas Rissing/iStock via Getty Images In the recent past, U.S. economic policy has been centered on the monetary policy of the Federal Reserve. Going back to 2008 or so, the dominating policy of the government has been the "quantitative" stance of the Federal Reserve System. The system was constructed and implemented while Ben Bernanke was the Chairman of the Fed's Board of Governors and then followed up on by Janet Yellen and Jay Powell when they served as the chairman. The primary tool of this policy system was the Fed's portfolio of securities. When the Fed conducted a policy of quantitative easing, it added securities to its portfolio, bought outright, and when it conducted a policy of quantitative tightening, it reduced the securities it had in its portfolio. Currently, the Federal Reserve is adding securities to its portfolio, so it is in a phase of quantitative easing. The latest policy program began in early December 2025. Four rounds of quantitative easing were run in the 2010s. One round of quantitative tightening was run from March 2020 up until early December last year. The Federal Reserve would establish a "policy stance" for its primary tool, and then it would manage its policy rate of interest, the Federal Funds rate, to be consistent with what was being done with the securities portfolio. This policy program, conducted by the Federal Reserve, served as the main economic policy of the Federal Government for the period between 2008 and the current time period. The Federal Government ran budget deficits during this period of time, but there was no real policy connection between what the Federal Government was doing and what the Federal Reserve was doing, so that the Federal budget was basically run independently of the monetary policy of the government. During this time, the Federal Government ran budget deficits and accumulated a substantial amount of debt. Here is a picture of the budget outcomes from 2001. Federal Surplus or Deficit (Federal Reserv...
Antitrust law has come into sharper focus over the past year, with several high-profile cases, including in Big Tech. Bilal Sayyed, former Director of the FTC’s Office of Policy Planning and current competition counsel at TechFreedom, as well as counsel at the law firm Cadwalader, Wickersham and Taft, joins Bloomberg Intelligence litigation analysts Jennifer Rie and Justin Teresi on this Votes and...
Antitrust law has come into sharper focus over the past year, with several high-profile cases, including in Big Tech. Bilal Sayyed, former Director of the FTC’s Office of Policy Planning and current competition counsel at TechFreedom, as well as counsel at the law firm Cadwalader, Wickersham and Taft, joins Bloomberg Intelligence litigation analysts Jennifer Rie and Justin Teresi on this Votes and Verdicts episode to talk about the state of US antitrust enforcement one year into the Trump admini
iQoncept/iStock via Getty Images As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factors such as valuation, growth, profitability, momentum, and estimate revisions after reporting quarterly performance. Of note, the State Street Health Care Select Sector...
iQoncept/iStock via Getty Images As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factors such as valuation, growth, profitability, momentum, and estimate revisions after reporting quarterly performance. Of note, the State Street Health Care Select Sector SPDR ETF ( XLV ) which accounts for a substantial 12.12% of the S&P 500, has emerged as a laggard in the current market environment. The XLV has retreated 3.00% year-to-date, outpacing the 2.53% slide seen in the benchmark index. Seeking Alpha’s Quant system rates stocks on a scale from 1 to 5, classifying ratings of 3.5 or above as bullish and 2.5 or below as bearish. Post-earnings quant scorecard: Below is a summary of mid-cap real estate companies with market capitalizations between $30M and $2B ranked by their current factor scores. Top-quant rated stocks: Q32 Bio ( QTTB ), Quant Rating: 4.98, Strong Buy. Ironwood Pharmaceuticals ( IRWD ), Quant Rating: 4.97, Strong Buy. Century Therapeutics ( IPSC ), Quant Rating: 4.96, Strong Buy. BioAge Labs ( BIOA ), Quant Rating: 4.95, Strong Buy. Armata Pharmaceuticals ( ARMP ), Quant Rating: 4.95, Strong Buy. Bottom quant rated stocks: Medicus Pharma ( MDCX ), Quant Rating: 1.00, Strong Sell. CERo Therapeutics Holdings ( CERO ), Quant Rating: 1.00, Strong Sell. Artelo Biosciences ( ARTL ), Quant Rating: 1.00, Strong Sell. CASI Pharmaceuticals ( CASIF ), Quant Rating: 1.00, Strong Sell. Gossamer Bio ( GOSS ), Quant Rating: 1.01, Strong Sell. More on State Street Health Care Select Sector SPDR ETF Sector Rotation: Healthcare XLV Should Be The Next Stop VT: Still The Best Approach To Passive Investing Market Sector Review: Extreme Market Bifurcation Eli Lilly tops growth factor grades among S&P healthcare holdings Energy surges to the top as long-only investors rebalance portfolios: BofA Research
Both Taiwan Semiconductor (NASDAQ:TSM) and Advanced Micro Devices (NASDAQ:AMD) have been great long-term picks for investors. That’s a fact most investors are well aware of. That said, these companies are very different in terms of their business models and underlying fundamentals. Let’s dive into the key differences, and which stock may be a better bet for long-term ... AMD vs. TSMC: Which Chip S...
Both Taiwan Semiconductor (NASDAQ:TSM) and Advanced Micro Devices (NASDAQ:AMD) have been great long-term picks for investors. That’s a fact most investors are well aware of. That said, these companies are very different in terms of their business models and underlying fundamentals. Let’s dive into the key differences, and which stock may be a better bet for long-term ... AMD vs. TSMC: Which Chip Stock Actually Delivers the Smarter Return in 2026?
I think there's solid bullish cases that can be made for both stocks, and I've made bull cases for each in the past. That said, I do think that ultimately the forward-looking risk-reward setup arguably favors TSMC, given its lower valuation (a forward price-earnings ratio of just 25-times, compared to the same ratio of more than 30-times for AMD). Other key fundamental metrics are similar, meaning...
I think there's solid bullish cases that can be made for both stocks, and I've made bull cases for each in the past. That said, I do think that ultimately the forward-looking risk-reward setup arguably favors TSMC, given its lower valuation (a forward price-earnings ratio of just 25-times, compared to the same ratio of more than 30-times for AMD). Other key fundamental metrics are similar, meaning that companies like AMD that may need to spend more on Capex to achieve the same amount of growth (I'd argue most of TSMC's Capex has been spent) could mean higher margins for the latter company over the long-term. AMD is the Nvidia ( NASDAQ:NVDA ) rival that's been absolutely crushing it in terms of total returns and capital appreciation in recent years. With soaring demand for GPUs and compute for AI and hosts of other high-growth sectors, essentially any sort of technological growth we're going to see is essentially going to come as a result of more and more semiconductor purchases over time. And with increasing pricing power, one could make the argument that AMD is the preferable way to play the AI trend right now. Taiwan Semiconductor, or TSMC as I'm going to refer to the company as throughout this piece, is the quiet enabler of almost everything tied to the AI revolution. Fabricating the very chips that power the world's most impressive high-performance computing chip makers such as AMD and its peers, TSMC has carved out a very unique and profitable niche in what's turned out to be among the fastest-growing economic sectors we've ever seen. That said, these companies are very different in terms of their business models and underlying fundamentals. Let's dive into the key differences, and which stock may be a better bet for long-term investors looking for top-tier ways to play the AI revolution right now. TSMC trades at a lower earnings multiple (mid-20s) despite driving a 60% CAGR in AI-linked revenue over the next several years, while AMD commands a premium valuatio...
Monty Rakusen/DigitalVision via Getty Images By Paolo Pizzoli , Senior Economist, Italy, Greece The first batch of hard data for 2026 confirms that, even before the start of the war in the Middle East, the path towards a gradual recovery for the Italian economy was not a smooth one. January production data, released today, were softer than expected. In January, seasonally adjusted industrial produ...
Monty Rakusen/DigitalVision via Getty Images By Paolo Pizzoli , Senior Economist, Italy, Greece The first batch of hard data for 2026 confirms that, even before the start of the war in the Middle East, the path towards a gradual recovery for the Italian economy was not a smooth one. January production data, released today, were softer than expected. In January, seasonally adjusted industrial production was down 0.6% on the month (from -0.5% in December), with consumer goods, intermediate goods and – more markedly – investment goods all in contraction and only energy goods expanding. The working days adjusted aggregate measure was down 0.6% on the year (from +2.7% in December), signalling that leaving the long-lasting manufacturing recession is not a smooth process. A quick look at the sector performance shows that hierarchies were partially reshuffled in January. After playing the role of the laggard throughout 2025, transport equipment production was second only to energy production in the yearly growth ranking. Electronic equipment production kept rising, while pharmaceuticals, the manufacturing growth leader in 2025, moved into negative territory in January. Chemicals were the worst performer, and textile and apparel were confirmed in contraction territory. Developments in industrial production for the rest of the year remain highly uncertain. Strong links with the German economy could eventually support Italian industry as Germany rolls out its infrastructure and defence investment plans, but evolving energy market tensions linked to the Middle East conflict are adding both supply- and demand‑side risks. February business surveys have not yet captured these pressures, instead pointing to flat production and steady orders, but the March data may tell a different story. After an unexpectedly strong 0.3% quarterly GDP rise in late 2025, we expect growth to cool in the first quarter of 2026. Content Disclaimer This publication has been prepared by ING solely for inf...
jetcityimage Carvana ( CVNA ) rallied after the company announced the first stock split in its history. The board approved a 5-for-1 split of its common stock. CFO Mark Jenkins said the auto retailer believes the stock split achieves the important goal of keeping its stock accessible to all team members. "This decision follows significant stock appreciation as Carvana reached new all-time records ...
jetcityimage Carvana ( CVNA ) rallied after the company announced the first stock split in its history. The board approved a 5-for-1 split of its common stock. CFO Mark Jenkins said the auto retailer believes the stock split achieves the important goal of keeping its stock accessible to all team members. "This decision follows significant stock appreciation as Carvana reached new all-time records for units and profitability while continuing to lead the industry in growth in 2025," he noted. Carvana ( CVNA ) highlighted that it has a long history of company-wide equity and benefits programs. All tenured full-time team members across all roles are eligible to earn equity through their years of service with Carvana ( CVNA ). The company also offers a discounted Employee Stock Purchase Plan to encourage and facilitate long-term team member ownership. The stock split proposal will be submitted for the approval of Carvana's ( CVNA ) stockholders. If approved at the company's annual meeting on May 5, each record holder of Class A and Class B common stock as of the close of market on May 6 will receive four additional shares of common stock. Trading is expected to commence on a split-adjusted basis at the market open on May 7. Carvana ( CVNA ) went public in an IPO in April 2017 at a pricing level of $15 per share. Shares of Carvana ( CVNA ) were up 3.4% to $302.44 in early action on Friday. More on Carvana Carvana Co. (CVNA) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript Carvana: Profitability Restored, But GPU Sensitivity Caps The Upside Carvana: Moving Ahead Despite A Profitability Speed Bump Wholesale used auto prices rose in February ahead of the spring selling season Carvana fails to impress investors; CFO defends accounting practices
Hims & Hers Health Inc. shares are on pace for their best week on record as a new partnership with Novo Nordisk A/S fuels fresh optimism about the company’s future in weight-loss drugs. The San Francisco-based company’s stock has climbed about 51% so far this week, as of Thursday’s close. Shares have rallied in three out of the past four trading sessions, bouncing to a one-month high. Earlier this...
Hims & Hers Health Inc. shares are on pace for their best week on record as a new partnership with Novo Nordisk A/S fuels fresh optimism about the company’s future in weight-loss drugs. The San Francisco-based company’s stock has climbed about 51% so far this week, as of Thursday’s close. Shares have rallied in three out of the past four trading sessions, bouncing to a one-month high. Earlier this week, the telehealth company said it would work with Novo to sell blockbusters Ozempic and Wegovy on its platform, ending a feud between the firms. Novo also agreed to drop a lawsuit it filed against Hims last month. In return, Hims will no longer advertise compounded versions of Novo’s drugs, but it will still sell copies of Ozempic and Wegovy if a doctor says a patient needs them. “This deal alleviated near term concerns while almost putting Hims back on the right path for long-term growth with a branded partner,” Needham & Co analyst Ryan MacDonald said in an interview. Investors are betting that the pact with Novo will likely drive growth and chart a path forward for the telehealth company that had been embroiled in legal and regulatory setbacks. And that this time, the agreement will stick. Novo ended its initial partnership with Hims in June, accusing it of using “deceptive marketing.” At the time, Novo executives said Hims wasn’t stepping back enough from its practice of mass marketing compounded versions of the weight-loss drugs. Investors dumped Hims’ stock as questions grew about the firm’s weight-loss business as well as the risk of lawsuits from the Danish company. The selloff worsened early this year when Novo sued Hims for launching a copycat version of the Wegovy pill, even after Hims swiftly pulled it from the market following regulatory threats. Hims also gave a weaker-than-expected profit outlook for the first quarter. That led to a 46% plunge in February, a record monthly drop. The stock was down 52% year-to-date, erasing $3.8 billion in market value, be...
In a surprising turnaround, SentinelOne (NYSE:S) stock slid roughly 4% in Friday morning trading before recovering; soon, it was up 3% on the day. Investors continue to weigh SentinelOne’s landmark $1 billion annual recurring revenue (ARR) milestone against a backdrop of decelerating growth, a CFO departure, and persistent GAAP losses that refuse to go away. ... SentinelOne Down 4%, Then Up 3%: Ca...
In a surprising turnaround, SentinelOne (NYSE:S) stock slid roughly 4% in Friday morning trading before recovering; soon, it was up 3% on the day. Investors continue to weigh SentinelOne’s landmark $1 billion annual recurring revenue (ARR) milestone against a backdrop of decelerating growth, a CFO departure, and persistent GAAP losses that refuse to go away. ... SentinelOne Down 4%, Then Up 3%: Can $1B Revenue Milestone Quell Skepticism?